Phase 3: the REDEFINE trials The Phase 3 programme for CagriSema is conducted under the name REDEFINE a series of large, randomised, controlled trials designed to confirm efficacy and establish the safety profile required for regulatory approval
Nr vi ftt in frsljningsdata bearbetas den av SCB -Statistiska Centralbyrn, s att vi tillsammans kan producera aktuell, trovrdig och samlad bostadsstatistik.
Factors such as BMI, medical history, current medications, and overall health goals all play a role in deciding if a lower-dose approach is safe and effective
Learn how this treatment works and the possible side effects
These measures can help make the process more manageable and ensure you stick to your injection schedule as planned
New Retatrutide is now available as a prefilled 3cc auto-injection pen cartridge (no reconstitution), ready for the V3 auto-injector pen kit